Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2005-01-18
2008-12-02
Eyler, Yvonne (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C514S095000, C514S079000, C514S080000, C514S081000, C514S089000, C514S096000, C548S414000, C546S023000, C558S169000
Reexamination Certificate
active
07459444
ABSTRACT:
The present invention is directed to a compound of formula (I),methods for preparing these compounds, compositions, intermediates and derivatives thereof, and methods for treating inflammatory and serine protease mediated disorders.
REFERENCES:
patent: 5508273 (1996-04-01), Beers et al.
patent: 6852734 (2005-02-01), Yamamoto et al.
patent: 0 661 260 (1995-07-01), None
patent: 1399089 (1971-05-01), None
Aoyama, Yasunori et al “Synthesis and Structure-Activity Relationships of a New Class of 1-Oxacephem-Based Human Chymase Inhibitors” Bioorganic & Medicinal Chemistry Letters 10 (2000) pp. 2397-2401 XP-002336087.
Bertrand, Jay A. et al “Inhibition of Trypsin and Thrombin by Amino(4-amidinophenyl)methanephosphonate Diphenyl Ester Derivatives: X-Ray Structures and Molecular Models” Biochemistry 35 (1996) pp. 3147-3155 XP-002336085.
Fukami, H. et al “Chymase: Its Pathophysiological Roles and Inhibitors” Current Pharmaceutical Design 4 (1998) pp. 439-453 XP-000885575.
Greco, Michael N. et al “Nonpeptide Inhibitors of Cathepsin G. Optimization of a Novel β-Ketophosphonic Acid Lead by Structure-Based Drug Design” J. Am. Chem. Soc. 124 (2002) pp. 3810-3811 XP002336084.
Lachkova, Victoria et al “Interaction Between Phenylmethanephosphonic Acid Diethyl Ester and Isothiocyanates” Phosphorus, Sulfur and Silicon 48 (1990) pp. 227-233 XP009050625.
Oleksyszyn, J et al “Irreversible Inhibition of Serine Proteases by Peptide Derivatives of (α-Aminoalkyl) phosphonate Diphenyl Esters” 30 (1991) pp. 485-493 XP002336086.
Tempest, P et al “MCC/SNAr Methodology, Part 1: Novel Access to a Range of Heterocyclic Cores” 42 (2001) pp. 4963-4968 XP002336083.
PCT International Search report PCT/US2005/001659 dated Aug. 3, 2005.
Schwender, Charles et al, “1-Naphthylmethyl Phosphonic Acid Derivatives as Osteoclastic Acid Phospatase Inhibitors,” Bioorganic and Medicinal Chemistry Letters, 1995, pp. 1801-1806, vol. 5, No. 16, Elsevier Science, Ltd., Great Britain.
De Lombaert et al., “Non-Peptide Inhibitors of Neutral Endopeptidase 24.11 2. Design and Pharmacology of Orally Active Phosphonate Prodrugs,” Bioorganic & Medicinal Chemistry Letters, 1995, pp. 151-154, vol. 5, No. 2, Elsevier Science Ltd., Great Britain.
De Lombaert et al., “N-Phosphonomethyl Dipeptides and Their Phosphonate Prodrugs, a New Generation of Neutral Endopeptidase (NEP, EC 3.4.24.11) Inhibitors,” J. Med Chem, 1994, pp. 498-511, vol. 37, American Chemical Society.
Okamoto et al., “Chymase Inhibitor, BCEAB, Suppressed Peritoneal Adhesion Formation in Hamster,” Journal Of Surgical Research, 2002, pp. 219-222, vol. 107, Elsevier Science (USA).
Yoa et al., “Association between the Expression of Mast Cell Chymase and Intraperitoneal Adhesion Formation in Mice,” Journal Of Surgical Research, 2000, pp. 40-44, vol. 92, Academic Press.
Lucas et al., “Formation of Abdominal Adhesions is Inhibited by Antibodies to Transforming Growth Factor-β1,” Journal Of Surgical Research, 1996, pp. 135-138, vol. 65, Academic Press.
Gotis-Graham et al., “Mast Cell Responses in Rheumatoid Synovium: Association of the MC sub TC subset with Matrix Turnover and Clinical Progession,” 1997, pp. 479-489, vol. 40 (3), American College of Rheumatology.
Lindstedt et al., “Chymase in Exocytosed Rat Mast Cell Granules Effectively Proteolyzes Apoliopoprotein Al-containing Lipoproteins, So Reducing the Cholesterol Efflux-inducing Ability of Serum and Aortic Intimal Fluid,” J Clin Invest, 1996, pp. 2174-2182, vol. 97, No. 10, The American Society for Clinical Investigation, Inc.
Gould et al., “Salt Selection for basic drugs,” International Journal Of Pharmaceutics, 1986, pp. 201-217, vol. 33, Elsevier Science Publichers, B.V.
De Paulis et al., “Novel Autocrine and Paracrine Loops of the Stem Cell Factor/Chymase Network,” Int Arch Allergy Immunol, 1999, pp. 422-425, vol. 118.
Ehara et al., “Contribution of mast cells to the tubulointerstitial lesions in IgA nephritis,” Kidney International, 1998, pp. 1675-83, vol. 54, International Society of Nephrology.
Graham et al., “Topically Active Carbonic Anhydrase Inhibitors,” J Med Chem., 1989, pp. 2548-2554, vol. 32, No. 12, American Chemical Society.
Henning et al., “Synthesis and Neuroleptic Activity of a Series of 1-[-1-(Benzo-1, 4-dioxan-2-ylmethyl)-4-piperidinyl]benzimidazolone Derivatives,” J Med Chem., 1987, pp. 814-19, vol. 30, American Chemical Society.
Egfange et al., “Modified Ibogaine Fragments: Synthesis and Preliminary Pharmacological Characterization of 3-Ethyl-5-phenly-1,2,3,4,5,6-hexahydroazepino[4,5-b] benzothiophenes,” J Med Chem, 1998, pp. 4486-91, vol. 41, American Chemical Society.
Ple et al., Synthesis of Substituted Benzo [b]thiophenes by Acid-Catalyzed.
Cyclization of Thiophenylacetals and Ketones, J. Heterocyclic Chem, 1988, pp. 1271, 25.
Steininger, “Uber die Herstellung von Bis-phosphiinigsaureestern und anderer Bix-phosphorverbindungen,” Chem Berg, 1963, pp. 3184-94, 96.
Cory et al., “Extended Chains of Six-Membered Rings 1. Model Studies and Key Intermediates,” Synthetic Communications, 1994, pp. 799-807, vol. 24, No. 6, Marcel Dekker, Inc.
Deprele et al., “Palladium-Catalyzed Hydrophosphinylation of Aikenes and Alkynes,” J. Am Chem Soc., 2002, pp. 9386-87, vol. 124, American Chemical Society.
Yamashiro et al., “Distribution of intrahepatic mast cells in various hepatolbiliary disorders,” Virchows Arch, 1998, pp. 471-79, vol. 433, Springer-Verlag.
Michele Reboud-Ravaux et al., Journal De La Societe De Biologie, Issn 1295-0661, 2001, pp. 143-150, vol. 195, No. 2.
Matsumoto et al., “Chymase Inhibition Prevents Cardiac Fibrosis and Improves Diastolic Dysfunction in the Progression of Heart Failure,” Circulation, pp. 2555-2558.
Paananen et al., “Proteolysis and Fusion of Low Density Lipoprotein Particles Independently Strengthen their Binding to Exocytosed Mast Cell Granules,” The Journal Of Biological Chemisty, 1994, pp. 2023-2031, vol. 269, No. 3, The American Society For Biochemistry And Molecular Biology, Inc., USA.
Longley et al., “Chymase cleavage of stem factor yields a bioactive soluble product,” Proc. National Acad., 1997, pp. 9017-9021, vol. 94, Biochemistry.
Froestl et al., “Phosphinic Acid Analogues of GABA. 1. New Potent and Selective GABAB,” J Med Chem, 1995, pp. 3297-3312, vol. 38, American Chemical Society.
Depaulis et al., “Novel Autocrine and Paracrine Loops of the Stem Cell Factor/Chymase Network,” Int Arch Allergy Immunol, 1999, pp. 4252-4425, vol. 118, Biology Of Inflammatory Products: Cytokines and Mediators.
Denney et al., “Osomeric Five-Membered Ring Phosphites and Phosphates,” Journal Of American Chemical Society, 1969, pp. 6838-6841, vol. 91, 24.
Deprele et al., “A novel and convenient preparation of hypophosphite esters,” Journal of Organometallic Chemistry, 2002, pp. 154-163, 643-644, Elsevier Science.
Garabadzhiu et al., “Actions of Perfluoroalkyl lodides Phosphorus (III) esters kinetics and mechanism of the reactions heptafluoropropyl with ethyl phosphonous eters,” Journal Of General Chemistry Ussr, 1982, pp. 1905-1910, Plenum Publishing Corporation.
Grasa et al., “Amination Reactions of Aryl Halides with Nitrogen-Containing Reagents Mediated by Palladium/Imidazolium Salt Systems,” J Org Chem, pp. 7729-7737, vol. 66.
Belley et al., “Synthesis of the Nanomolar Photoaffinity GABABReceptor Ligand CGP 71872 Reveals Diversity in the Tissue Distribution of GABABReceptor Forms,” Bioorganic and Medicinal Chemistry, 1999, pp. 2697-2704, vol. 7, Elsevier Science Ltd.
Martinez et al., “New 3-[4-(aryl)piperazin-1-yl]-1-(benzol[b]thiophen-3-yl)propane derivatives with dual action
de Garavilla Lawrence
Greco Michael N.
Hawkins Michael J.
Maryanoff Bruce E.
Powell Eugene
Eyler Yvonne
Janssen Pharmaceutica N.V.
Valenrod Yevgeny
LandOfFree
Inhibitors of chymase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of chymase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of chymase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4028793